RE:RE:RE:RE:ONCY announces positive Phase 2 Bracelet-1 results in mBCLooks like some on this message board who identify themselves as watching movies should stick to watching movies.
It is evident that these same movie watchers have a very limited understanding of the cancer domain and instead are "glued" to just the SP, which a BP acquirer considers irrelevant. It has been observed many times over that BP wants to acquire late-stage scientifically sound assets that are de-risked, that fit with their "core" business and product pipeline. ONCY's pelareorep has well positioned itself to closely align with these Big Pharma's objectives.